T. Rowe Price Value Adv (PAVLX)
37.46
+0.35
(+0.94%)
USD |
Mar 31 2023
Key Stats
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.97% | 26.97B | 1.42% | 192.1% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -6.415B | -9.46% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to provide long-term capital appreciation by investing in common stocks believed to be undervalued; income is a secondary objective. At least 65% of the fund's total assets will normally be invested in common stocks that the portfolio manager regards as undervalued. The fund may purchase stocks issued by companies of any size, but typically focuses its investments on large-cap stocks. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | TRVLX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Global Category Name | US Equity Large Cap Value |
| YCharts Categorization | US Large Cap Value |
| YCharts Benchmark | Russell 1000 Value Total Return (^RLVTR) |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | T. Rowe Price |
| Prospectus Benchmark Index | |
| Russell 1000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Ryan Hedrick | 0.16 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
100
-6.415B
-6.415B
Category Low
13.81B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of February 28, 2023
Risk
Performance Versus Category
As of March 31, 2023. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of March 31, 2023.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Elevance Health Inc | 3.81% | 459.81 | 0.19% |
| Johnson & Johnson | 3.41% | 155.00 | 1.02% |
| Southern Co | 3.19% | 69.58 | 0.75% |
| Bank of America Corp | 3.11% | 28.60 | 1.06% |
| Exxon Mobil Corp | 3.05% | 109.66 | 0.16% |
| Becton, Dickinson and Co | 2.84% | 247.54 | 0.97% |
| JPMorgan Chase & Co | 2.63% | 130.31 | 1.21% |
| Philip Morris International Inc | 2.53% | 97.25 | 0.65% |
| Alphabet Inc Class C | 2.26% | 103.96 | 2.60% |
| The Travelers Companies Inc | 2.24% | 171.41 | 0.35% |
Basic Info
| Investment Strategy | |
| The investment seeks to provide long-term capital appreciation by investing in common stocks believed to be undervalued; income is a secondary objective. At least 65% of the fund's total assets will normally be invested in common stocks that the portfolio manager regards as undervalued. The fund may purchase stocks issued by companies of any size, but typically focuses its investments on large-cap stocks. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | TRVLX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Global Category Name | US Equity Large Cap Value |
| YCharts Categorization | US Large Cap Value |
| YCharts Benchmark | Russell 1000 Value Total Return (^RLVTR) |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | T. Rowe Price |
| Prospectus Benchmark Index | |
| Russell 1000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Ryan Hedrick | 0.16 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (3-31-23) | 1.42% |
| 30-Day SEC Yield (3-27-23) | Upgrade |
| 7-Day SEC Yield (3-31-23) | Upgrade |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 16.73 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of December 31, 2022
Fund Details
| Key Dates | |
| Inception Date | 3/31/2000 |
| Last Annual Report Date | 12/31/2022 |
| Last Prospectus Date | 5/1/2022 |
| Share Classes | |
| TRPIX | Inst |
| TRVLX | No Load |
| TRZAX | Inst |
| Attributes | |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |